BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1216 related articles for article (PubMed ID: 19441749)

  • 1. [House dust mite allergy: myths and realities].
    Bouton C; Ducommun J
    Rev Med Suisse; 2009 Apr; 5(199):832-6. PubMed ID: 19441749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study.
    Werfel T; Breuer K; Ruéff F; Przybilla B; Worm M; Grewe M; Ruzicka T; Brehler R; Wolf H; Schnitker J; Kapp A
    Allergy; 2006 Feb; 61(2):202-5. PubMed ID: 16409197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
    Gallego MT; Iraola V; Himly M; Robinson DS; Badiola C; García-Robaina JC; Briza P; Carnés J
    Int Arch Allergy Immunol; 2010; 153(1):61-9. PubMed ID: 20357486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergy to house dust mites and asthma.
    Milián E; Díaz AM
    P R Health Sci J; 2004 Mar; 23(1):47-57. PubMed ID: 15125219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. House dust mites on skin, clothes, and bedding of atopic dermatitis patients.
    Teplitsky V; Mumcuoglu KY; Babai I; Dalal I; Cohen R; Tanay A
    Int J Dermatol; 2008 Aug; 47(8):790-5. PubMed ID: 18717857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of an acaricide in management of house dust mite allergy.
    Brown HM; Merrett TG
    Ann Allergy; 1991 Jul; 67(1):25-31. PubMed ID: 1859037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Allergy to house dust mites: allergy independent symptoms dominate].
    Herwig LM; Helbling A; Pichler WJ; Pichler CE
    Praxis (Bern 1994); 2004 Feb; 93(8):267-73. PubMed ID: 15032137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of skin prick test and atopy patch test in mite-induced respiratory allergy and/or atopic eczema/dermatitis syndrome].
    Fuiano N; Incorvaia C
    Minerva Pediatr; 2004 Oct; 56(5):537-40. PubMed ID: 15459578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real-life clinical practice.
    Ferrés J; Justicia JL; García MP; Muñoz-Tudurí M; Alvà V
    Allergol Immunopathol (Madr); 2011; 39(3):122-7. PubMed ID: 20570032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of sublingual immunotherapy for house dust mite-induced allergic rhinitis and its co-morbid conditions.
    Chan AW; Luk WP; Fung LH; Lee TH
    Immunotherapy; 2019 Nov; 11(16):1387-1397. PubMed ID: 31608757
    [No Abstract]   [Full Text] [Related]  

  • 11. [Allergy to house dust mites].
    Schnyder B; Schweri T; Thomann B; Pichler C
    Schweiz Med Wochenschr; 2000 Mar; 130(12):443-7. PubMed ID: 10780059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Respiratory allergy to house dust: Dermatophagoides pteronyssinus versus Dermatophagoides farinae] ].
    Popović-Grle S
    Lijec Vjesn; 2001; 123(9-10):233-7. PubMed ID: 11845577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children.
    Yonekura S; Okamoto Y; Sakurai D; Horiguchi S; Hanazawa T; Nakano A; Kudou F; Nakamaru Y; Honda K; Hoshioka A; Shimojo N; Kohno Y
    Allergol Int; 2010 Dec; 59(4):381-8. PubMed ID: 20864799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basophil degranulation test in house dust mite allergy: diagnostic value.
    Feliu X; de la Cuesta CG; Castillo JG; Sanz ML; Oehling A
    Allergol Immunopathol (Madr); 1989; 17(4):193-6. PubMed ID: 2479246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [House dust mites in the etiology of allergic diseases].
    Henszel Ł; Kuźna-Grygiel W
    Ann Acad Med Stetin; 2006; 52(2):123-7. PubMed ID: 17633128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative studies of the effectiveness of specific immunotherapy in house dust mite allergy].
    Ebner H; Neuchrist C; Havelec L; Kraft D
    Wien Klin Wochenschr; 1989 Aug; 101(15):504-11. PubMed ID: 2672610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety of subcutaneous immunotherapy with tyrosine-adsorbed house dust mite extracts in patients with allergic disease].
    Molina-Sáenz MM; Villa-Arango AM; Cardona-Villa R
    Rev Alerg Mex; 2017; 64(1):52-65. PubMed ID: 28188713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sensitization to house dust mite allergens: diagnosis--therapy].
    Zimmermann T
    Wien Med Wochenschr; 1989 Apr; 139(6-7):122-6. PubMed ID: 2658338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: results of an observational open controlled parallel group study in real-life setting.
    Marogna M; Spadolini I; Massolo A
    Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):135-42. PubMed ID: 15916014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acarofauna in the apartments of patients with perennial atopic rhinitis and functional tests of the respiratory system].
    Mincewicz G; Aloszko A; Racewicz M; Stańczak J
    Pol Merkur Lekarski; 2003 Jan; 14(79):17-20. PubMed ID: 12712821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.